DescriptionSARS-CoV-2 Neutralizing Recombinant Monoclonal Antibody is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2. Clone: DA0002
FormulationLiquid. Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2, with 10% Trehalose.
HostSARS-CoV-2
SourceHuman
SpecificitySARS-CoV-2
IsotypeIgG1 (Human)
PurificationAffinity Purification; >95% by SDS-PAGE
Endotoxin< 0.1 EU/μg of the protein by LAL method.
StorageStore the lyophilized protein at -20°C to -80 °C for long term. Avoid repeated freeze/thaw cycles.
Alternative NamesAnti-coronavirus NP Antibody, Anti-coronavirus Nucleocapsid Antibody, Anti-coronavirus Nucleoprotein Antibody, Anti-cov np Antibody, Anti-ncov NP Antibody, Anti-novel coronavirus NP Antibody, Anti-novel coronavirus Nucleocapsid Antibody, Anti-novel coronavirus Nucleoprotein Antibody, Anti-NP Antibody, Anti-Nucleocapsid Antibody, Anti-Nucleoprotein Antibody; SARS-CoV-2; 2019-nCoV
ApplicationELISA: Recommended dilution: ELISA 1:250 – 1:1000